Ionis Pharmaceuticals Inc at Nasdaq Investor Conference (Virtual) Transcript
Good morning, everyone. Thank you for your participation in this year's 44th Annual NASDAQ Investor Conference. We would not be able to be here without your involvement. We're excited to host you and to having to share your story with European investors.
This is Ionis' first time currently at our London conference, and we are so thrilled to have you. We hope that all the speakers enjoyed their gift of Fortnum & Mason hamper filled with an assortment of tea and goodies, which will hopefully remind you of London and help in the early mornings of this conference.
You are joined by several of your peers as we welcome around a record number of 51 companies to the conference, 15 of which are NASDAQ 100 companies.
On the investor side, we are welcoming over 500 investors, representing approximately $13 trillion in assets under management, which far surpasses the 400 investors we posted last year.
The all-time high demonstrates a very strong appetite for investors to connect you virtually in this format. The investors join us from across the globe. 52% of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |